Matthias Zachert

Lanxess to Sell Reverse Osmosis Arm

German chemical producer Lanxess is realigning its water treatment business, divesting its reverse osmosis membrane activities to Suez and strengthening its ion exchange resins business to focus on high-end specialty applications.

Stephen Forsyth to Become Chief Integration Officer at Lanxess

Lanxess Takes Chemours’ Disinfectants Business

Lanxess CEO Says China Concerns Overblown

Lanxess Picks Saudi Aramco as Rubber Partner

Lanxess Talking to Ineos About Rubber

Lanxess to Leave German DAX 30

Global Chemicals Markets Still Volatile and Challenging

Lanxess Realignment Progressing Rapidly, CEO Says

Lanxess Improves Earnings in Fiscal 2014

Lanxess to Maintain Dividend at 50 Cents

Lanxess In Talks With Minority Partner for Rubber

Lanxess Says 2014 Earnings Exceed Expectations

Stratmann to Head Lanxess’ New Investor Function

Lanxess CEO Confirms Plans for Substantial Job Cuts

Lanxess Realignment Could See 1,200 Jobs Go

The Steep Climb Back to Profit

Germany's Merck Halts Supply of Cancer Drug to Greek Hospitals

Merck KGaA to Cut Costs, Jobs Despite Record Revenues in 2011

Dr. Bernhard Düttmann to Become Chief Financial Officer (CFO) of Lanxess

CFO Matthias Zachert Jumps From Lanxess To Merck